Target intelligence / Profile preview

microRNA 367 (miR-367)

Target
miR-367
Molecular classification
MicroRNA, Non-coding RNA, Other
01

Overview

microRNA 367 (miR-367) is a small, non-coding RNA molecule that belongs to the miR-302/367 cluster located intronically in the La-related protein 7 (LARP7) gene. It functions primarily as a regulator of gene expression at the post-transcriptional level by binding to specific sequences in the 3′ untranslated regions (3′UTRs) of target messenger RNAs, resulting in inhibition of translation or mRNA degradation. miR-367 plays crucial roles in cell proliferation, pluripotency maintenance, differentiation, cell cycle regulation, and reprogramming. It is highly expressed in embryonic stem cells and induced pluripotent stem cells but is also implicated in cancer biology, acting as both a tumor suppressor and, in some contexts, an oncogene. miR-367 has been experimentally validated to regulate genes such as PIK3R3 and RYR3, among others, and is involved in major signaling pathways such as PI3K–AKT, TGF-β/Nodal, and BMP. Its expression and function are tightly regulated, and genetic variants affecting miR-367 binding sites can influence disease susceptibility, especially cancer.

Other names
hsa-mir-367MIRN367MIR367mir-367
02

Mechanism of action

Inhibition of mRNA translation or promotion of mRNA degradation by direct binding to the 3′ UTR of target genes. Modulation of cellular signaling pathways, e.g., PI3K–AKT, BMP, TGF-β/Nodal/Smad, through downregulation of key pathway components.

03

Biological functions

Regulation of gene expression (post-transcriptional silencing)Cell proliferationDifferentiationPluripotency maintenanceCell cycle regulationEpigenetic regulationSelf-renewalReprogrammingInvasion/metastasis (in cancer)
04

Disease associations

Cancer (tumor suppressor and oncogene roles in different contexts)Pluripotency-related diseasesOther (varies by cell type and context)
05

Safety considerations

Potential oncogenic effects in certain cancer types when dysregulatedPossible off-target or pleiotropic effects impacting cell fate, pluripotency, or differentiation if modulated therapeutically
06

Biomarkers

Expression of miR-367 as a biomarker for certain cancers (e.g., oral squamous cell carcinoma, medulloblastoma) and pluripotent stem cell statusPolymorphisms affecting miR-367 binding sites (e.g., RYR3 3′UTR rs1044129) as risk markers for cancer

Beyond the preview

Go deeper on microRNA 367 (miR-367).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on microRNA 367 (miR-367).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call